Anna Frączek

Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial

Scott E. Kasner, Balakumar Swaminathan, Pablo M. Lavados et al. · The Lancet Neurology · 2018 · 178 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Long-term nusinersen treatment across a wide spectrum of spinal muscular atrophy severity: a real-world experience

Anna Łusakowska, Adrianna Wójcik, Anna Frączek et al. · Orphanet Journal of Rare Diseases · 2023 · 59 citations · Full text

Medicine, Neurology, Pediatrics +16

Ultra-low radiation dose protocol for CT-guided intrathecal nusinersen injections for patients with spinal muscular atrophy and severe scoliosis

Grzegorz Rosiak, Anna Łusakowska, Krzysztof Milczarek et al. · Neuroradiology · 2021 · 42 citations · Full text

Medicine, Radiology, Interventional Radiology +14

Spinal muscular atrophy: epidemiology and health burden in children — a Polish national healthcare database perspective before introduction of SMA-specific treatment

Anna Kostera‐Pruszczyk, Łukasz Napiórkowski, Krystyna Szymańska et al. · Neurologia i Neurochirurgia Polska · 2021 · 10 citations · Full text

Medicine, Child Health, Pediatrics +8